Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preventive Antibiotics in Stroke Study
ISRCTN66140176Phase 3Completed
- Sponsor
- Amsterdam University Medical Center
- Start
- May 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of ceftriaxone in stroke (2 arms), sponsored by Amsterdam University Medical Center. Primary endpoint: functional outcome at 3 months. Started May 2010; status: completed.
02
Drugs
ceftriaxone
03
Conditions
stroke
Beyond the preview
Go deeper on ISRCTN66140176.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN66140176.